Quetiapine in Social Anxiety Disorder
Social Anxiety Disorder
About this trial
This is an interventional treatment trial for Social Anxiety Disorder focused on measuring quetiapine, social anxiety disorder, antipsychotic, pilot study
Eligibility Criteria
Inclusion Criteria: adult outpatients 18-65 years of age primary diagnosis of social anxiety disorder, using DSM-IV criteria minimum CGI severity score of 4 at baseline minimum BSPS score of 20 at baseline written informed consent negative serum pregnancy test for women of childbearing potential Exclusion Criteria: current DSM-IV diagnosis of bipolar disorder, schizophrenia or other psychotic disorder, or cognitive disorder due to a general medical condition any current primary anxiety disorder other than SAD or current primary depression history of substance abuse or dependence with the last 6 months suicide risk or serious suicide attempt within the last year clinically significant medical condition or laboratory abnormality women of childbearing potential who are unwilling to practice an acceptable method of contraception concomitant medication use for psychotropic purposes history of hypersensitivity to quetiapine
Sites / Locations
- Duke University Medical Center